Familial Mediterranean fever, inflammation and nephrotic syndrome: Fibrillary glomerulopathy and the M6801 missense mutation

BMC Nephrology

Volumn 4, Issue , 2003, Pages 1-7

  Fisher, Patrick W ^a   Ho, L Tammy ^a   Goldschmidt, Robert ^a   Semerdjian, Ronald J ^a   Rutecki, Gregory W ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE;

ADULT; AMYLOIDOSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE EXACERBATION; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GLOMERULONEPHRITIS; GLOMERULOPATHY; HETEROZYGOTE; HUMAN; INFLAMMATION; MALE; MISSENSE MUTATION; NEPHROTIC SYNDROME; TREATMENT FAILURE; GENETICS; MIDDLE AGED;

FAMILIAL MEDITERRANEAN FEVER; GLOMERULONEPHRITIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MUTATION, MISSENSE; NEPHROTIC SYNDROME;

EID: 3042577545     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-4-6     Document Type: Article

References (22)

1. Sohar E, Merker HJ, Missmahl HP, Gafni J and Heller H: Electron-microscope observations on peri-reticulin and peri-collagen amyloidosis in rectal biopsies. J Pathol Bacteriol 1967, 94:89-93.
2. Reiman H: Periodic disease. Probable syndrome including periodic fever. JAMA 1948, 136:239-244.
3. Matzner Y: Biologic and clinical advances in familial mediterranean fever. Review of Oncology and Hematology 1995, 18:197-295.
4. Shohat M, Magel N, Shohat T, Chen X, Dagan T, Mimouni A, Danon Y, Lotan R, Ogur G, Sirin A, Schlezinger M, Halpern GJ, Schwabe A, Kastner D, Rotter JI and N F-G: Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999, 3:287-292.
5. Zemer DPM, Sohar E, Modan M, Cabili S and Gafni J: Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Eng J Med 1986, 314:1001-1005.
6. Tekin M, Yalcinkaya F, Tumer N, Cakar N, Kocak H, Ozkaya N and Gencgonul H: Familial Mediterranean fever - renal involvement by diseases other than amyloid. Nephrol Dial Transplant 1999, 14:475-479.
7. Pras EAI, Gruberg L, Balow JE, Prosen L, Dean M, Steinberg AD, Pras M and Kastner DL: Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Eng J Med 1992, 326:1509-1513.
8. A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat Genet 1997, 17:25-31.
9. Ancient missense mutations in a new member of the Ro-Ret gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997, 90:797-807.
10. Pras M: Familial Mediterranean fever: from clinical syndrome to the cloning of the Pyrin gene. Scand J Rheumatol 1998, 27:92-97.
11. Mimouni A, Magal N, Stoffman N, Shohat T, Minasian A, Krasnov M, Halpern GJ, Rotter JI, Fischel-Ghodsian N, Danon YL and Shohat M: Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics 2000, 105:E70.
12. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S and Pras M: Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997, 40:1879-1885.
13. Eisenberg S, Aksentijevich I, Deng Z, Kastner DL and Matzner YI: Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med 1998, 129:539-542.
14. Schwartz MM, Korbet SM and Lewis EJ: Immunotactoid Glomerulopathy. J Am Soc Nephrol 2002, 13:1390-1397.
15. Korbet S, Schwartz S and Lewis E: The Fibrillary Glomerulopathies. Am J Kidney Dis 1994, 23:751-765.
16. Iskandar SS, Falk RJ and Jennette JC: Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int 1992, 42:1401-1407.
17. Mitchell A: Cell signalling: pyrin fever. Nat Rev Mol Cell Biol 2002, 3:150.
18. Guijarro C and Egido J: Transcription factor-Kappa B (Nf-Kappa B) and renal disease. Kidney Int 2001, 59:415-424.
19. Ray A and Ray B: Persistent expression of serum amyloid A during experimentally induced chronic inflammatory condition in rabbit involves differential activation of SAF, Nf-Kappa B, and C/Ebp transcription factors. J Immunol 1999, 163:2143-2150.
20. Lawrence T, Gilroy GW, Colville-Nash PR and Willoughby D: Possible new role for Nf-Kappa B in the resolution of Inflammation. Nat Med 2001, 7:1291-1297.
21. Manji G, Wang L, Geddes B, Brown M, Merriam S, Al-Garawi A, Mak S, Lora J, Briskin M, Jurman M, Cao J, DiStefano P and Bertin J: PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-Kappa B. J Biol Chem 2002, 277:11570-11575.
22. Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M and Pras E: MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 1999, 6:1-6.